Pitcairn CO Coherus Bio Sciences, Inc. Transaction History

Pitcairn CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 28, 2020	SELL	$14.43 - $19.16 $256,392 - $340,434	-17,768 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$11.67 - $22.53 $56,261 - $108,617	4,821 Added 37.24%	17,768 $288,000
Q4 2019 Feb 12, 2020	BUY	$16.33 - $21.37 $17,734 - $23,207	1,086 Added 9.16%	12,947 $233,000
Q3 2019 Nov 12, 2019	BUY	$16.3 - $23.37 $193,334 - $277,191	11,861 New	11,861 $240,000

132

77.3M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $87.1M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

Stay updated on Pitcairn CO with notifications on news.